Bevacizumab/carboplatin/paclitaxel regimen

{
  "id": "MLC-T-ONC-011995",
  "term": "Bevacizumab/carboplatin/paclitaxel regimen",
  "field": "Oncology and biomedicine",
  "definition": "A regimen consisting of bevacizumab, carboplatin and paclitaxel that can be used in the treatment of endometrial, ovarian, fallopian tube and primary peritoneal, vulvar and cervical cancers and non-small cell lung cancer (NSCLC).",
  "synonyms": [
    "carboplatin-paclitaxel-bevacizumab regimen",
    "carboplatin-Taxol-bevacizumab regimen",
    "carbo-Taxol-Avastin regimen",
    "carboplatin-paclitaxel-bevacizumab",
    "carboplatin-Taxol-bevacizumab",
    "carboplatin/paclitaxel/bevacizumab"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bevacizumab-carboplatin-paclitaxel-regimen/"
}